scorpinone: a natural azaanthraquinone produced by a Bispora-like tropical fungus; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 11000531 |
| CHEMBL ID | 1164378 |
| MeSH ID | M0404017 |
| Synonym |
|---|
| inchi=1/c16h13no4/c1-8-4-10-12(7-17-8)16(19)14-11(15(10)18)5-9(20-2)6-13(14)21-3/h4-7h,1-3h |
| CHEMBL1164378 |
| scorpinone |
| 7,9-dimethoxy-3-methylbenzo[g]isoquinoline-5,10-dione |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID487386 | Inhibition of human PC3M cell migration at 5 uM by wound-healing assay | 2010 | Journal of natural products, Jun-25, Volume: 73, Issue:6 | Maximizing chemical diversity of fungal metabolites: biogenetically related Heptaketides of the endolichenic fungus Corynespora sp. (1). |
| AID487387 | Inhibition of cell proliferation in human PC3M cells at 5 uM after 40 hrs by MTT assay | 2010 | Journal of natural products, Jun-25, Volume: 73, Issue:6 | Maximizing chemical diversity of fungal metabolites: biogenetically related Heptaketides of the endolichenic fungus Corynespora sp. (1). |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.56) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||